Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RV

Robert Veltri — 18 Patents

URUrocor: 9 patents #1 of 13Top 8%
LHLaboratory Corporation Of America Holdings: 1 patents #97 of 163Top 60%
NRNational Foundation For Cancer Research: 1 patents #3 of 7Top 45%
TTThe University Of Tulsa: 1 patents #41 of 101Top 45%
The Johns Hopkins University: 1 patents #1,989 of 476Top 420%
West Chester, PA: #99 of 1,305 inventorsTop 8%
Pennsylvania: #3,897 of 74,527 inventorsTop 6%
Overall (All Time): #245,716 of 4,157,543Top 6%
18 Patents All Time
Robert Veltri has been granted 18 US patents while listed as an inventor at Urocor. The first was granted in 1985 and the most recent in August 2011. Robert Veltri ranks #245,716 of 4,157,543 US inventors in our database (top 5.9%). Patent records list Robert Veltri in West Chester, PA, US.

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7993830 Prostate-specific gene for diagnosis, prognosis and management of prostate cancer Gang An 2011-08-09
7332270 Diagnosis of disease state using mRNA profiles in peripheral leukocytes David A. Ralph, Gang An, S. Mark O'Hara 2008-02-19
6463438 Neural network for cell image analysis for identification of abnormal cells Kaveh Ashenayi, Ying Hu, Gerard J. O'Dowd 2002-10-08
6369195 Prostate-specific gene for diagnosis, prognosis and management of prostate cancer Gang An 2002-04-09
6218529 Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer Gang An, S. Mark O'Hara, David A. Ralph 2001-04-17 $2,132,000
6190857 Diagnosis of disease state using MRNA profiles in peripheral leukocytes David A. Ralph, Gang An, S. Mark O'Hara 2001-02-20 $1,985,000
6156515 Prostate-specific gene for diagnosis, prognosis and management of prostate cancer Gang An 2000-12-05 $2,303,000
6025128 Prediction of prostate cancer progression by analysis of selected predictive parameters Michael Patrick Bacus, M. Craig Miller, Kaveh Ashenayi, Donald P. Coffey, Alan W. Partin +1 more 2000-02-15
5989811 Sextant core biopsy predictive mechanism for non-organ confined disease status M. Craig Miller, Michael Patrick Bacus, Kaveh Ashenayi 1999-11-23 $663,000
5882864 Biomarkers and targets for diagnosis, prognosis and management of prostate disease Gang An, S. Mark O'Hara, David A. Ralph 1999-03-16 $915,000
5856112 Method for selectively inducing biomarker expression in urologic tumor tissue for diagnosis and treatment thereof Garry M. Marley 1999-01-05 $1,110,000
5102909 Pharmaceutically useful furyl substituted dihydroxyethylbutyrolactones Gabor Fodor, Kawporn Sussangkarn 1992-04-07
5098933 Pharmaceutically useful Michael addition products of unsaturated aldehydes and ketones and ascorbic acid Gabor Fodor 1992-03-24
4963364 Microencapsulated antitumor agent Sidney W. Fox 1990-10-16
4883808 Condensation products of cyclic diketones and ascorbic acid as immunomodulatory agents Gabor Fodor, Kawporn Sussangkarn 1989-11-28
4883813 Method of treating inflammation in mammals utilizing ketobutyrolactones and furylbutyrolactones Peter E. Maxim 1989-11-28
4617262 Assaying for circulating immune complexes with labeled protein A Peter E. Maxim 1986-10-14 $1,286,000
4518611 2-Furylbutyrolactone modulation of the immune system in mammals 1985-05-21